# Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy

> **NCT00693017** · PHASE3 · TERMINATED · sponsor: **Eisai Limited** · enrollment: 10 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Zonisamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00693017
- **Lead sponsor:** Eisai Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2008-11
- **Final completion:** —
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Sponsor's decision
- **Last updated:** 2015-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00693017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00693017, "Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00693017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*